Form 4: Cullinan Therapeutics' Chief Scientific Officer Sells Shares to Cover Tax Obligations

Jennifer Michaelson, Chief Scientific Officer of Cullinan Therapeutics, sold 3,756 shares of common stock to cover personal income tax obligations upon the vesting of restricted stock units.

Summary

• On February 25, 2025, Jennifer Michaelson, the Chief Scientific Officer of Cullinan Therapeutics, Inc. (CGEM), sold 3,756 shares of common stock.
• The shares were sold at a price of $8.53 per share.
• This transaction was executed to cover personal income tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Michaelson directly owns 142,004 shares of Cullinan Therapeutics.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, as it simply reports a transaction.

Industry Context

Form 4 filings are a routine part of the US stock market, and are required by the SEC to provide transparency when company insiders trade their company's stock. This filing indicates that the Chief Scientific Officer sold shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by a company insider could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the reason for the sale (tax obligations) and the relatively small number of shares involved.

Key Dates